These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29754804)

  • 1. Diabetes mellitus and cardiovascular risk: Update of the recommendations of the Diabetes and Cardiovascular Disease working group of the Spanish Diabetes Society (SED, 2018).
    Arrieta F; Iglesias P; Pedro-Botet J; Becerra A; Ortega E; Obaya JC; Nubiola A; Maldonado GF; Campos MDM; Petrecca R; Pardo JL; Sánchez-Margalet V; Alemán JJ; Navarro J; Duran S; Tébar FJ; Aguilar M; Escobar F;
    Clin Investig Arterioscler; 2018; 30(3):137-153. PubMed ID: 29754804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus and cardiovascular risk: an update of the recommendations of the Diabetes and Cardiovascular Disease Working Group of the Spanish Society of Diabetes (SED, 2021).
    Arrieta F; Pedro-Botet J; Iglesias P; Obaya JC; Montanez L; Maldonado GF; Becerra A; Navarro J; Perez JC; Petrecca R; Pardo JL; Ribalta J; Sánchez-Margalet V; Duran S; Tébar FJ; Aguilar M
    Clin Investig Arterioscler; 2022; 34(1):36-55. PubMed ID: 34330545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetes mellitus and cardiovascular risk: Working group recommendations of Diabetes and Cardiovascular Disease of the Spanish Society of Diabetes (SED, 2015)].
    Arrieta F; Iglesias P; Pedro-Botet J; Tébar FJ; Ortega E; Nubiola A; Pardo JL; Maldonado GF; Obaya JC; Matute P; Petrecca R; Alonso N; Sarabia E; Sánchez-Margalet V; Alemán JJ; Navarro J; Becerra A; Duran S; Aguilar M; Escobar-Jiménez F;
    Aten Primaria; 2016 May; 48(5):325-36. PubMed ID: 26031458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetes mellitus and cardiovascular risk: Working group recommendations of Diabetes and Cardiovascular Disease of the Spanish Society of Diabetes (SED, 2015)].
    Arrieta F; Iglesias P; Pedro-Botet J; Tébar FJ; Ortega E; Nubiola A; Pardo JL; Maldonado GF; Obaya JC; Matute P; Petrecca R; Alonso N; Sarabia E; Sánchez-Margalet V; Alemán JJ; Navarro J; Becerra A; Duran S; Aguilar M; Escobar-Jiménez F;
    Clin Investig Arterioscler; 2015; 27(4):181-92. PubMed ID: 25825221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines and their use in clinical practice.
    Shaw JA; Cooper ME
    Diab Vasc Dis Res; 2014 Jan; 11(1):3-4. PubMed ID: 24344118
    [No Abstract]   [Full Text] [Related]  

  • 6. Diet and lifestyle guidelines and desirable levels of risk factors for the prevention of diabetes and its vascular complications in Indians: a scientific statement of The International College of Nutrition. Indian Consensus Group for the Prevention of Diabetes.
    Singh RB; Rastogi SS; Rao PV; Das S; Madhu SV; Das AK; Sahay BK; Fuse SM; Beegom R; Sainani GS; Shah NA
    J Cardiovasc Risk; 1997 Jun; 4(3):201-8. PubMed ID: 9475675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Type 2 diabetes mellitus and cardiovascular risk factors: is comprehensive treatment required?].
    Nadal JF; Gutiérrez PC
    Med Clin (Barc); 2013 Sep; 141 Suppl 2():7-13. PubMed ID: 24444518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus document of the Spanish Society of Arteriosclerosis (SEA) for the prevention and treatment of cardiovascular disease in type 2 diabetes mellitus.
    Ruiz-García A; Arranz-Martínez E; Morón-Merchante I; Pascual-Fuster V; Tamarit JJ; Trias-Villagut F; Pintó-Sala X; Ascaso JF;
    Clin Investig Arterioscler; 2018 Jul; 30 Suppl 1():1-19. PubMed ID: 30053980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential implications of the choice among three alternative treatment targets for apolipoprotein B100 in the management of patients with type 2 diabetes and chronic kidney disease.
    Boronat M; García-Cantón C; López-Ríos L; Quevedo V; Lorenzo DL; Batista F; Riaño M; Nóvoa FJ
    Diab Vasc Dis Res; 2014 Jan; 11(1):53-9. PubMed ID: 24254975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: established knowledge and evidence gaps.
    Paneni F
    Diab Vasc Dis Res; 2014 Jan; 11(1):5-10. PubMed ID: 24254974
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical decisions in patients with diabetes and other cardiovascular risk factors. A statement of the Spanish Society of Internal Medicine.
    Gómez-Huelgas R; Pérez-Jiménez F; Serrano-Ríos M; González-Santos P; Román P; Camafort M; Conthe P; García-Alegría J; Guijarro R; López-Miranda J; Tirado-Miranda R; Valdivielso P; ;
    Rev Clin Esp (Barc); 2014 May; 214(4):209-15. PubMed ID: 24602600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diabetes mellitus in cardiology practice in Spain. Survey by the Working Group on Heart and Diabetes regarding the importance of diabetes mellitus in relation with other cardiovascular diseases].
    Palma Gámiz JL; Hernández Madrid A; Bertomeu Martínez V; González-Juanatey JR; López García-Aranda V; Calderón Montero A; Alegría Ezquerra E; Cadierno Carpintero M;
    Rev Esp Cardiol; 2004 Jul; 57(7):661-6. PubMed ID: 15274851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention.
    Brotons C; Camafort M; Castellanos MDM; Clarà A; Cortés O; Diaz Rodriguez A; Elosua R; Gorostidi M; Hernández AM; Herranz M; Justo S; Lahoz C; Niño P; Pallarés-Carratalá V; Pedro-Botet J; Pérez Pérez A; Royo-Bordonada MA; Santamaria R; Tresserras R; Zamora A; Zuza I; Armario P
    Clin Investig Arterioscler; 2022; 34(4):219-228. PubMed ID: 35906022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice].
    Royo-Bordonada MÁ; Armario P; Lobos Bejarano JM; Pedro-Botet J; Villar Alvarez F; Elosua R; Brotons Cuixart C; Cortés O; Serrano B; Cammafort Babkowski M; Gil Núñez A; Pérez A; Maiques A; de Santiago Nocito A; Castro A; Alegría E; Baeza C; Herranz M; Sans S; Campos P;
    Hipertens Riesgo Vasc; 2017; 34(1):24-40. PubMed ID: 28017552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
    Raum E; Lietzau S; Stegmaier C; Brenner H; Rothenbacher D
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):485-94. PubMed ID: 18383562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention].
    Brotons C; Camafort M; Del Mar Castellanos M; Clarà A; Cortés O; Diaz Rodriguez A; Elosua R; Gorostidi M; Hernández AM; Herranz M; Justo S; Lahoz C; Niño P; Pallarés-Carratalá V; Pedro-Botet J; Pérez Pérez A; Royo-Bordonada MA; Santamaria R; Tresserras R; Zamora A; Zuza I; Armario P
    Hipertens Riesgo Vasc; 2022; 39(2):69-78. PubMed ID: 35331672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spanish Diabetes Society (SED) recommendations for the pharmacologic treatment of hyperglycemia in type 2 diabetes: 2018 Update.
    Gomez-Peralta F; Escalada San Martín FJ; Menéndez Torre E; Mata Cases M; Ferrer García JC; Ezkurra Loiola P; Ávila Lachica L; Fornos Pérez JA; Artola Menéndez S; Álvarez-Guisasola F; Rica Echevarría I; Girbés Borrás J;
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):611-624. PubMed ID: 30366843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and management of cardiovascular disease in patients with diabetes mellitus: an evidence base.
    Yudkin JS; Blauth C; Drury P; Fuller J; Henley J; Lancaster T; Lankester J; Lean M; Pentecost B; Press V; Rothman D
    Diabet Med; 1996 Sep; 13(9 Suppl 4):S101-21. PubMed ID: 8894461
    [No Abstract]   [Full Text] [Related]  

  • 19. [Consensus document on the treatment of dyslipidemia in diabetes].
    Hormigo-Pozo A; Mancera-Romero J; Perez-Unanua MP; Alonso-Fernandez M; Lopez-Simarro F; Mediavilla-Bravo JJ;
    Semergen; 2015 Mar; 41(2):89-98. PubMed ID: 25533449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice].
    Royo-Bordonada MÁ; Armario P; Lobos Bejarano JM; Pedro-Botet J; Villar Álvarez F; Elosua R; Brotons Cuixart C; Cortés O; Serrano B; Camafort Babkowski M; Gil Núñez A; Pérez A; Maiques A; de Santiago Nocito A; de Castro A; Alegría E; Baeza C; Herranz M; Sans S; Campos P;
    Gac Sanit; 2017; 31(3):255-268. PubMed ID: 28292529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.